G

GemPharmatech Co Ltd
SSE:688046

Watchlist Manager
GemPharmatech Co Ltd
SSE:688046
Watchlist
Price: 15.37 CNY 1.79% Market Closed
Market Cap: 3.1B CNY

Intrinsic Value

The intrinsic value of one GemPharmatech Co Ltd stock under the Base Case scenario is 20.03 CNY. Compared to the current market price of 15.37 CNY, GemPharmatech Co Ltd is Undervalued by 23%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
20.03 CNY
Undervaluation 23%
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case

Valuation History
GemPharmatech Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about GemPharmatech Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is GemPharmatech Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for GemPharmatech Co Ltd.

Explain Valuation
Compare GemPharmatech Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about GemPharmatech Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
GemPharmatech Co Ltd

Current Assets 1.8B
Receivables 432m
Other Current Assets 1.4B
Non-Current Assets 1B
Long-Term Investments 111m
PP&E 654m
Intangibles 59m
Other Non-Current Assets 215m
Current Liabilities 543m
Accounts Payable 68m
Accrued Liabilities 40m
Short-Term Debt 255m
Other Current Liabilities 180m
Non-Current Liabilities 86m
Long-Term Debt 58m
Other Non-Current Liabilities 28m
Efficiency

Free Cash Flow Analysis
GemPharmatech Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
GemPharmatech Co Ltd

Revenue
752.7m CNY
Cost of Revenue
-287.2m CNY
Gross Profit
465.5m CNY
Operating Expenses
-340.4m CNY
Operating Income
125.1m CNY
Other Expenses
-3.6m CNY
Net Income
121.5m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

GemPharmatech Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Positive 3Y Average ROIC
Sustainable 3Y Average Operating Margin
49/100
Profitability
Score

GemPharmatech Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

GemPharmatech Co Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
77/100
Solvency
Score

GemPharmatech Co Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
GemPharmatech Co Ltd

Wall Street analysts forecast GemPharmatech Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GemPharmatech Co Ltd is 21.31 CNY with a low forecast of 21.1 CNY and a high forecast of 21.93 CNY.

Lowest
Price Target
21.1 CNY
37% Upside
Average
Price Target
21.31 CNY
39% Upside
Highest
Price Target
21.93 CNY
43% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for GemPharmatech Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one GemPharmatech Co Ltd stock?

The intrinsic value of one GemPharmatech Co Ltd stock under the Base Case scenario is 20.03 CNY.

Is GemPharmatech Co Ltd stock undervalued or overvalued?

Compared to the current market price of 15.37 CNY, GemPharmatech Co Ltd is Undervalued by 23%.

Back to Top